1. Catalogs
  2. Poclight
  3. The Gold Standard in Cardiac Risk Stratification

The Gold Standard in Cardiac Risk Stratification

The Gold Standard in Cardiac Risk Stratification

The Gold Standard in Cardiac Risk Stratification

Product catalog summary
Ultra-High Sensitivity and Early Diagnostic Capability
High-sensitivity cardiac troponin T (hs-cTnT) is crucial for early detection and monitoring of myocardial injury, enhancing diagnostic accuracy for acute coronary syndrome (ACS). It is particularly valuable in emergency settings for rapid rule-out of acute myocardial infarction (AMI) with high negative predictive value.
Exceptional Analytical Precision and Standardization
hs-cTnT assays are standardized across platforms, ensuring high comparability and consistency. This contrasts with hs-cTnI assays, which show variability due to inconsistent antibody targets.
Clinical Prognosis and Risk Stratification Value
hs-cTnT provides substantial prognostic value for cardiovascular outcomes, including heart failure and sudden cardiac death. It is especially effective in predicting all-cause mortality in emergency department patients, outperforming hs-cTnI.
Clinical Applications
hs-cTnT is used across various departments, including cardiology, nephrology, and emergency intensive care units. It is critical for differentiating chronic from acute myocardial injury, particularly in patients with chronic kidney disease and the elderly.
Sex Differences
Baseline hs-cTnT levels are higher in healthy males than females, influenced by myocardial mass and hormonal factors.
Comparative Analysis: hs-cTnT vs hs-cTnI
Both assays have comparable diagnostic accuracy for NSTEMI, but hs-cTnT shows superior performance in early-phase diagnosis and prognostic utility.
Technical Specifications of C5000 Dry Micro System
The system offers rapid detection with a throughput of 80 tests/hour, is semi-automatic and portable, and supports real-time information sharing. It is economical and efficient, with a touch screen interface and no need for complex liquid paths.
See more

Catalog excerpts

The Gold Standard in Cardiac Risk Stratification  -1

The Gold Standard in Cardiac Risk Stratification ––– Detecting Myocardial Injury at the Molecular Level for Precise Prognosis ● Ultra-High Sensitivity and Early Diagnostic Capability ● Exceptional Analytical Precision and Standardization ● Clinical Prognosis and Risk Stratification Value Cardiology Department Nephrology Department Oncology Department Intensive Care Physical Unit, ICU Examinati

 Open the catalog to page 1
The Gold Standard in Cardiac Risk Stratification  -2

Introduction High-sensitivity cardiac troponin T (hs-cTnT) is a critical component of the regulatory protein complex governing myocardial contraction, primarily localized within the myofibrils of cardiomyocytes and existing in a bound ternary complex with cardiac troponin I (cTnI) and troponin C (cTnC). Clinically, dynamic serial measurements of hs-cTnT provide substantial prognostic value for evaluating cardiovascular outcomes, including risks of heart failure and sudden cardiac death. Clinical Significance High-sensitivity cardiac troponin T (hs-cTnT) is the gold standard for early detection...

 Open the catalog to page 2
The Gold Standard in Cardiac Risk Stratification  -3

Time to Initial Elevation Molecular Release:hs-cTnT circulates predominantly as intact ternary complexes (cTnI-cTnC-cTnT) and free monomers, whereas hs-cTnI exists as fragmented, post-translationally modified isoforms (oxidized, phosphorylated) with minimal intact monomer stability. Assay Standardization:hs-cTnT assays employ standardized epitopes across platforms, ensuring inter-assay comparability, while hs-cTnI assays exhibit variability due to inconsistent antibody targets (e.g., 1+1 vs. 2+2 designs), hindering harmonization. Diagnostic Accuracy: Both assays show comparable overall diagnostic...

 Open the catalog to page 3
The Gold Standard in Cardiac Risk Stratification  -4

Applicable System ^Poclight Nanjing Poclight Biotechnology Co., Ltd. Address: South Side, 2nd Floor, Building A02, Biopharmaceutical Valley Accelerator (Phase III), No. 142 Huakang Road, Jiangbei New District, Nanjing City, Jiangsu Province, 210000, P R. China E-mail: [email protected] Website: www.poclight.com

 Open the catalog to page 4
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.